Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01529346 · ClinicalTrials.gov registry record · Phase 2
Efficacy Of PF-05089771 In Treating Postoperative Dental Pain
A Phase 2 study of Postoperative Dental Pain, sponsored by Pfizer.
- Completed
- Registry status
- Phase 2
- Development phase
- 235
- Enrollment target
- 3
- Study locations
NCT01529346 is a Phase 2 study of Postoperative Dental Pain that has completed, run by Pfizer. The registered enrollment target is 235 participants. The trial reports 3 study locations across 1 state.
The verdict
NCT01529346, a Phase 2 study of Postoperative Dental Pain, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 235 participants
- Enrollment target
- 3
- Study locations
Study Summary
The objective of this study is to evaluate the overall pain relief of a single dose of PF-05089771 against placebo following third molar extraction.
Conditions Studied
Interventions
- OTHER Placebo
- DRUG PF-05089771
Study Locations (3)
Texas
- Central Texas Oral Surgery Associates - Austin
- Premier Research Group Limited - Austin
- PPD Development, LP - Austin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 235 participants |
| Start Date | 2011-12-12 |
| Est. Completion | 2012-06-25 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01529346
The ClinicalTrials.gov registry entry for NCT01529346 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 235 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Postoperative Dental Pain appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT01529346 reports 3 study locations spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT01529346 about?
NCT01529346 is a clinical study titled "Efficacy Of PF-05089771 In Treating Postoperative Dental Pain". The objective of this study is to evaluate the overall pain relief of a single dose of PF-05089771 against placebo following third molar extraction.
What is the current status of trial NCT01529346?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 235 participants. The study started on 2011-12-12. Estimated completion is 2012-06-25.
What conditions does trial NCT01529346 study?
This clinical trial studies the following conditions: Postoperative Dental Pain.
What interventions are being tested in trial NCT01529346?
The interventions under investigation include: Placebo (OTHER), PF-05089771 (DRUG).
Who is sponsoring clinical trial NCT01529346?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01529346 being conducted?
This trial has 3 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.